Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. mcdermottshaunagh@gmail.comIssue Date
2013MeSH
Diagnostic ImagingEvidence-Based Medicine
Gastrointestinal Neoplasms
Humans
Neoplasm Staging
Neuroendocrine Tumors
Pancreatic Neoplasms
Prognosis
Metadata
Show full item recordCitation
Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach., 37 (2):194-200 Clin ImagingJournal
Clinical imagingDOI
10.1016/j.clinimag.2012.05.006PubMed ID
23465968Abstract
In contrast to other common types of malignant tumors, the vast majority of gastroenteropancreatic neuroendocrine tumors are well differentiated and slowly growing with only a minority showing aggressive behavior. It is important to accurately stage patients radiologically so the correct treatment can be implemented and to improve prognosis. In this article, we critically appraise the current literature in an effort to establish the current role of radiologic imaging in the staging of neuroendocrine tumors. We also discuss our protocol for staging neuroendocrine tumors.Item Type
ArticleLanguage
enISSN
1873-4499ae974a485f413a2113503eed53cd6c53
10.1016/j.clinimag.2012.05.006